ABI1 | Abl-interactor 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | ![](/images/29973/if_selected_60x60.jpg) | ![](/images/8375/ihc_cell_selected_60x60.jpg) | ![](/images/8375/20046_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
ABL1 | C-abl oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | ![](/images/27280/ihc_cell_selected_60x60.jpg) | ![](/images/28409/61493_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
ABL2 | C-abl oncogene 2, non-receptor tyrosine kinase | Cancer-related genes Enzymes RAS pathway related proteins
| ![](/images/1866/ihc_selected_60x60.jpg) | | ![](/images/1866/ihc_cell_selected_60x60.jpg) | ![](/images/17106/38942_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
ACSL3 | Acyl-CoA synthetase long-chain family member 3 | Cancer-related genes Enzymes Mitochondrial proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/11315/ihc_cell_selected_60x60.jpg) | ![](/images/11315/29351_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
AFF3 | AF4/FMR2 family, member 3 | Cancer-related genes
| ![](/images/44512/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/44512/99012_B_9_7_rna_selected_60x60.jpg) | Mixed |
AFF4 | AF4/FMR2 family, member 4 | Cancer-related genes Disease related genes
| ![](/images/23690/ihc_selected_60x60.jpg) | | ![](/images/23690/ihc_cell_selected_60x60.jpg) | ![](/images/23690/51734_A_3_3_rna_selected_60x60.jpg) | Expressed in all |
AKAP9 | A kinase (PRKA) anchor protein 9 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | ![](/images/8548/ihc_cell_selected_60x60.jpg) | ![](/images/8548/23971_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | ![](/images/2891/7679_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
AKT2 | V-akt murine thymoma viral oncogene homolog 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | ![](/images_static/na_center.gif) | ![](/images/4204/ihc_cell_selected_60x60.jpg) | ![](/images/4204/11545_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
APC | Adenomatous polyposis coli | Cancer-related genes Disease related genes Plasma proteins
| | ![](/images/13349/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/13349/42951_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | Cancer-related genes Disease related genes
| | ![](/images/18911/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/18911/47233_A_2_3_rna_selected_60x60.jpg) | Expressed in all |
ARID1A | AT rich interactive domain 1A (SWI-like) | Cancer-related genes Disease related genes Transcription factors
| | | ![](/images/16334/ihc_cell_selected_60x60.jpg) | ![](/images/5456/19570_B_7_3_rna_selected_60x60.jpg) | Expressed in all |
ARID2 | AT rich interactive domain 2 (ARID, RFX-like) | Cancer-related genes Transcription factors
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
ARNT | Aryl hydrocarbon receptor nuclear translocator | Cancer-related genes Transcription factors
| | | | ![](/images/4318/11330_B_1_7_rna_selected_60x60.jpg) | Expressed in all |
ASPSCR1 | Alveolar soft part sarcoma chromosome region, candidate 1 | Cancer-related genes Disease related genes
| ![](/images/26749/ihc_selected_60x60.jpg) | | ![](/images/26749/ihc_cell_selected_60x60.jpg) | ![](/images/26749/58071_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
ATF1 | Activating transcription factor 1 | Cancer-related genes Disease related genes Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/16222/36028_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/13462/28449_B_2_4_rna_selected_60x60.jpg) | Expressed in all |
ATM | Ataxia telangiectasia mutated | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/102/ihc_cell_selected_60x60.jpg) | ![](/images/102/2518_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18702/42623_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/1583/5182_B_7_5_rna_selected_60x60.jpg) | Group enriched |
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | ![](/images/1906/ihc_cell_selected_60x60.jpg) | ![](/images/1906/7642_B_3_2_rna_selected_60x60.jpg) | Expressed in all |
AXIN1 | Axin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | ![](/images/12987/ihc_cell_selected_60x60.jpg) | ![](/images/12987/28845_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
BAP1 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) | Cancer-related genes Disease related genes Enzymes Potential drug targets
| ![](/images/4322/ihc_selected_60x60.jpg) | | ![](/images/28814/ihc_cell_selected_60x60.jpg) | ![](/images/4322/11863_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| ![](/images/29003/ihc_selected_60x60.jpg) | | | ![](/images/29003/123910_B_8_8_rna_selected_60x60.jpg) | Mixed |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Transcription factors
| ![](/images/49117/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/49117/110537_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
BCL2 | B-cell CLL/lymphoma 2 | Cancer-related genes Disease related genes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins
| ![](/images/3/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/3/1332_B_2_6_rna_selected_60x60.jpg) | Expressed in all |
BCL3 | B-cell CLL/lymphoma 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| ![](/images/2051/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/2051/5530_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
BCL6 | B-cell CLL/lymphoma 6 | Cancer-related genes Disease related genes Transcription factors
| | ![](/images/4899/if_selected_60x60.jpg) | ![](/images/4899/ihc_cell_selected_60x60.jpg) | ![](/images/307/846_A_7_1_rna_selected_60x60.jpg) | Expressed in all |
BCL7A | B-cell CLL/lymphoma 7A | Cancer-related genes Disease related genes
| ![](/images/19762/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/19762/105119_B_8_3_rna_selected_60x60.jpg) | Expressed in all |
BCR | Breakpoint cluster region | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | ![](/images/38337/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38337/81434_B_8_7_rna_selected_60x60.jpg) | Expressed in all |
BIRC3 | Baculoviral IAP repeat containing 3 | Cancer-related genes Disease related genes Plasma proteins
| ![](/images/2317/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/2317/8878_B_8_7_rna_selected_60x60.jpg) | Mixed |
BLM | Bloom syndrome, RecQ helicase-like | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| ![](/images/5689/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/5689/20573_B_7_8_rna_selected_60x60.jpg) | Tissue enriched |
BRAF | V-raf murine sarcoma viral oncogene homolog B | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | ![](/images_static/na_center.gif) | | ![](/images/1328/3905_B_2_3_rna_selected_60x60.jpg) | Expressed in all |
BRCA1 | Breast cancer 1, early onset | Cancer-related genes Disease related genes Plasma proteins
| | | ![](/images/1946/ihc_cell_selected_60x60.jpg) | ![](/images/34966/89240_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
BRCA2 | Breast cancer 2, early onset | Cancer-related genes Disease related genes
| ![](/images/26815/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/26815/59972_B_9_1_rna_selected_60x60.jpg) | Mixed |
BRD4 | Bromodomain containing 4 | Cancer-related genes Disease related genes
| | | ![](/images_static/rna_center.gif) | ![](/images/68178/152032_A_8_7_rna_selected_60x60.jpg) | Expressed in all |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | ![](/images/5474/ihc_cell_selected_60x60.jpg) | ![](/images/5474/16185_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | Cancer-related genes Disease related genes Enzymes Potential drug targets
| ![](/images/8419/ihc_selected_60x60.jpg) | | ![](/images/8419/ihc_cell_selected_60x60.jpg) | ![](/images/8419/23045_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
CALR | Calreticulin | Cancer-related genes Plasma proteins Predicted secreted proteins
| ![](/images/2242/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/2242/8395_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
CAMTA1 | Calmodulin binding transcription activator 1 | Cancer-related genes Disease related genes
| ![](/images/36343/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/36343/77668_B_6_7_rna_selected_60x60.jpg) | Expressed in all |
CANT1 | Calcium activated nucleotidase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | ![](/images/22818/if_selected_60x60.jpg) | ![](/images/19627/ihc_cell_selected_60x60.jpg) | ![](/images/19627/45534_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
CARD11 | Caspase recruitment domain family, member 11 | Cancer-related genes Disease related genes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52984/127686_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | ![](/images/2384/8118_A_1_7_rna_selected_60x60.jpg) | Expressed in all |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | ![](/images/26624/56299_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CASP8 | Caspase 8, apoptosis-related cysteine peptidase | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets
| ![](/images/1302/ihc_selected_60x60.jpg) | | ![](/images/1302/ihc_cell_selected_60x60.jpg) | ![](/images/1302/30721_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
CBL | Cbl proto-oncogene, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes
| | | ![](/images/27956/ihc_cell_selected_60x60.jpg) | ![](/images/4350/11497_B_2_7_rna_selected_60x60.jpg) | Mixed |
CBLB | Cbl proto-oncogene B, E3 ubiquitin protein ligase | Cancer-related genes
| ![](/images/18327/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/19880/45308_B_7_2_rna_selected_60x60.jpg) | Expressed in all |
CCDC6 | Coiled-coil domain containing 6 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | ![](/images/19049/46013_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
CCND1 | Cyclin D1 | Cancer-related genes Disease related genes FDA approved drug targets
| ![](/images/24/ihc_selected_60x60.jpg) | | | ![](/images/24/71_B_8_6_rna_selected_60x60.jpg) | Mixed |
CCND2 | Cyclin D2 | Cancer-related genes
| ![](/images/49138/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/49138/110514_A_3_5_rna_selected_60x60.jpg) | Mixed |